Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amprenavir/Ritonavir vs Saquinavir/Ritonavir in HIV after Kaletra Failure
NCT00038519Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2001
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of amprenavir, saquinavir in human immunodeficiency virus infection (HIV), sponsored by Abbott Laboratories. Started Apr 2001; status: completed.
02
Drugs
amprenavirsaquinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00038519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038519.